JO
BNGO icon

John Overdeck’s Bionano Genomics BNGO Stock Holding History

John Overdeck’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,513
Closed -$62K – 4599
2025
Q4 		$62K Buy
+40,513
New +$70.1K ﹤0.01% 3912
2025
Q1 		– Sell
-225
Closed -$3.89K – 3218
2024
Q4 		$3.89K Sell
225
-170
-43% -$2.91K ﹤0.01% 3155
2024
Q3 		$10.7K Buy
+395
New +$12.3K ﹤0.01% 3047
2024
Q1 		– Sell
-6,790
Closed -$770K – 3043
2023
Q4 		$770K Buy
+6,790
New +$709K ﹤0.01% 2226
2022
Q4 		– Sell
-632
Closed -$694K – 2812
2022
Q3 		$694K Sell
632
-539
-46% -$712K ﹤0.01% 1627
2022
Q2 		$970K Buy
1,171
+994
+562% +$1.02M ﹤0.01% 1559
2022
Q1 		$274K Buy
+177
New +$239K ﹤0.01% 2242
2021
Q3 		– Sell
-626
Closed -$2.75M – 4244
2021
Q2 		$2.75M Sell
626
-151
-19% -$596K 0.01% 1612
2021
Q1 		$3.77M Buy
+777
New +$4.38M 0.01% 1246
2020
Q1 		– Sell
-96
Closed -$71K – 3131
2019
Q4 		$71K Buy
+96
New +$56.1K ﹤0.01% 3546

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

John Overdeck's BNGO Position: Q1 2026 in Review

John Overdeck sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 40,513 shares — an estimated $62K sold.

John Overdeck first reported a position in BNGO in Q4 2019 and held it in 10 quarters. The position peaked at $3.77M in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • John Overdeck reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 40,513 Bionano Genomics shares in Q1 2026, an estimated $62K.
  • John Overdeck first reported a position in Bionano Genomics in Q4 2019 and held it in 10 quarters.
  • John Overdeck's Bionano Genomics position peaked at $3.77M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.